As the geriatric population continues to grow, so does the challenge of polypharmacy. This article outlines strategies to effectively manage polypharmacy and optimize patient outcomes.
Polypharmacy, the concurrent use of multiple medications, is common among the elderly due to the prevalence of chronic diseases. While necessary, it can lead to adverse drug events, drug interactions, and decreased adherence to medication regimens.
A comprehensive medication review is the cornerstone of polypharmacy management. Regularly reviewing the patient's medication list, including over-the-counter drugs and supplements, can identify unnecessary medications, therapeutic duplications, and potential drug interactions.
Deprescribing, the systematic process of identifying and discontinuing drugs in instances where existing or potential harms outweigh current or future benefits, is a key strategy in managing polypharmacy. It requires careful consideration of the patient's overall health status, life expectancy, and preferences.
Pharmacists, as medication experts, have a critical role in managing polypharmacy. They can provide medication therapy management, counsel patients about their medications, and collaborate with other healthcare professionals to optimize medication use.
Technology can assist in managing polypharmacy. Clinical decision support systems can alert healthcare professionals to potential drug-drug interactions, inappropriate dosing, and other medication-related issues.
In conclusion, effective management of polypharmacy in the geriatric population requires a multifaceted approach that includes a comprehensive medication review, deprescribing, pharmacist-led interventions, and the use of technology. By implementing these strategies, healthcare professionals can improve medication safety and patient outcomes in this vulnerable population.
1.
Make the Diagnosis: Can You Explain Her Rash and Conjunctival Injection?
2.
Should the UK introduce targeted prostate cancer screening? The case for and against
3.
Real-World EV Plus Pembro Success Seen in Urothelial Cancer
4.
In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.
5.
Investigating the Relationship Between GERD and Anxiety/Depression.
1.
Building Physical Resilience in Chronic Blood Disorders
2.
Can AI Become Our Oncologic Ally? A Look at Artificial Intelligence in Cancer Detection and Control
3.
Artificial Intelligence for Spatial Tumor Evolution Reconstruction
4.
What are Acanthocytes? Understanding the Role of Spiky Red Blood Cells
5.
Harnessing Cuproptosis: A Novel Nanomedicine Strategy for Triple-Negative Breast Cancer
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
2.
Understanding Risk Factors Associated With Common Cancers
3.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
4.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
5.
The Role of Hemoglobin in Maintaining Healthy Oxygen Levels
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation